Serotype distribution and clinical characteristics associated with streptococcus pneumoniae among Chinese children and adults with invasive pneumococcal disease: a multicenter observational study

References

• Pneumococcal vaccines WHO position paper. 2012. [accessed 2017 Oct]. (http://www.who.int/wer/2012/wer8714.pdf?ua=1
   Google Scholar
• Estimated Hib and pneumococcal deaths for children under 5 years of age. 2008.[accessed 2017 Oct]. (http://www.who.int/immunization_monitoring/burden/Pneumo_hib_estimates/en/index.html
   Google Scholar
• Kyaw MH, Christie P, Clarke SC, Mooney JD, Ahmed S, Jones IG, Campbell H. Invasive pneumococcal disease in Scotland, 1999–2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis. 2003;37(10):1283–91. doi:10.1086/379016.
   PubMed Web of Science ®Google Scholar
• Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med. 2009;30(2):189–209. doi:10.1055/s-0029-1202938.
   PubMed Web of Science ®Google Scholar
• Reinert RR, Haupts S, van der Linden M, Heeg C, Cil MY, Al-Lahham A, Fedson DS. Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001–2003. Clin Microbiol Infect. 2005;11(12):985–91. doi:10.1111/j.1469-0691.2005.01282.x.
   PubMed Web of Science ®Google Scholar
• Hung IF, Tantawichien T, Tsai YH, Patil S, Zotomayor R. Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention. Int J Infect Dis. 2013;17(6):e364–e373. doi:10.1016/j.ijid.2013.01.004.
   PubMed Web of Science ®Google Scholar
• Drijkoningen JJ, Rohde GG. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect. 2014;20(Suppl 5):45–51. doi:10.1111/1469-0691.12461.
   PubMed Web of Science ®Google Scholar
• Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14(3):e197–209. doi:10.1016/j.ijid.2009.05.010.
   PubMed Web of Science ®Google Scholar
• Klugman KP, Black S, Dagan R, Malley R, Whitney CG. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines. In: Plotkin SA, Orenstein WA, Offit P editors. Vaccines. 6th. Philadelphia (PA): WB Saunders Company; 2008. p. 504–42.
   Google Scholar
• Karstaedt AS, Khoosal M, Crewe-Brown HH. Pneumococcal bacteremia during a decade in children in Soweto, South Africa. Pediatr Infect Dis J. 2000;9(5):454–57. doi:10.1097/00006454-200005000-00012.
   Google Scholar
• Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, et al. Gambian pneumococcal vaccine trial group. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in the Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005;365(9465):1139–46. doi:10.1016/S0140-6736(05)71876-6.
   PubMed Web of Science ®Google Scholar
• Mufson MA, Stanek RJ. Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978–1997. Am J Med. 1999;107(1):34S–43S. doi:10.1016/S0002-9343(99)00098-4.
   PubMed Web of Science ®Google Scholar
• Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L, McGeer A, Farley MM, Vugia DJ, Lexau C, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997. Am J Public Health. 2000;90:223–29.
   PubMed Web of Science ®Google Scholar
• Rock C, Sadlier C, Fitzgerald J, Kelleher M, Dowling C, Kelly S, Bergin C. Epidemiology of invasive pneumococcal disease and vaccine provision in a tertiary referral center. Eur J Clin Microbiol Infect Dis. 2013;32(9):1135–41. doi:10.1007/s10096-013-1859-z.
   PubMed Web of Science ®Google Scholar
• Thomas K, Mukkai Kesavan L, Veeraraghavan B, Jasmine S, Jude J, Shubankar M, Kulkarni P, Steinhoff M. IBIS study group IndiaCLEN network. invasive pneumococcal disease associated with high case fatality in India. J Clin Epidemiol. 2013;66(1):36–43. doi:10.1016/j.jclinepi.2012.04.006.
   PubMed Web of Science ®Google Scholar
• Song JY, Choi JY, Lee JS, Bae IG, Kim YK, Sohn JW, Jo YM, Choi WS, Lee J, Park KH, et al. Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study. BMC Infect Dis. 2013;13(1):202. doi:10.1186/1471-2334-13-202.
   PubMed Web of Science ®Google Scholar
• Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol. 1995;33(10):2759–62. doi:10.1128/JCM.33.10.2759-2762.1995.
   PubMed Web of Science ®Google Scholar
• Alanee SR, McGee L, Jackson D, Chiou CC, Feldman C, Morris AJ, Ortqvist A, Rello J, Luna CM, Baddour LM, et al. International pneumococcal study group. association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis. 2007;45(1):46–51. doi:10.1086/518538.
   PubMed Web of Science ®Google Scholar
• Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O’Brien KL. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7:pii: e1000348. doi:10.1371/journal.pmed.1000348.
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, et al. Active bacterial core surveillance of the emerging infections program network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006;354:1455–63. doi:10.1056/NEJMoa051642.
   PubMed Web of Science ®Google Scholar
• Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, et al. Active bacterial core surveillance/emerging infections program network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201(1):32–41. doi:10.1086/648593.
   PubMed Web of Science ®Google Scholar
• van Werkhoven CH, Hollingsworth RC, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Sanders EA, Bonten MJ. Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly. Vaccine. 2016;34(28):3275–82. doi:10.1016/j.vaccine.2016.05.002.
   PubMed Web of Science ®Google Scholar
• Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011;378(9807):1962–73. doi:10.1016/S0140-6736(10)62225-8.
   PubMed Web of Science ®Google Scholar
• van der Linden M, Imöhl M, Perniciaro S. Limited indirect effects of an infant pneumococcal vaccination program in an aging population. PLoS One. 2019;14:e0220453. doi:10.1371/journal.pone.0220453.
   PubMed Web of Science ®Google Scholar
• Yao KH, Wang LB, Zhao GM, Zheng YJ, Deng L, Huang JF, Wang JX, Zhao RZ, Deng QL, Hu YH, Yu SJ, Yang YH, Young M. Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumonia. Vaccine. 2011;29(12):2296–301. doi:10.1016/j.vaccine.2011.01.027.
   PubMed Web of Science ®Google Scholar
• Kong Y, Zhang W, Jiang Z, Wang L, Li C, Li Y, Xia J. Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in Chinese healthy population aged>2 years: a randomized, double-blinded, active control, phase III trial. Hum Vaccin Immunother. 2015;11:2425–33. doi:10.1080/21645515.2015.1055429.
   PubMed Web of Science ®Google Scholar
• Li Y, An Z, Yin D, Liu Y, Huang Z, Ma Y, Li H, Li Q, Wang H. Disease burden of community acquired pneumonia among children under 5 y old in China: A population based survey. Hum Vaccin Immunother. 2017;13(7):1681–87. doi:10.1080/21645515.2017.1304335.
   PubMed Web of Science ®Google Scholar
• Mo X, Gai Tobe R, Liu X, Mori R. Cost-effectiveness and health benefits of pediatric 23-valent pneumococcal polysaccharide vaccine, 7-valent pneumococcal conjugate vaccine and forecasting 13-valent pneumococcal conjugate vaccine in China. Pediatr Infect Dis J. 2016;35(11):e353–e361. doi:10.1097/INF.0000000000001288.
   PubMed Web of Science ®Google Scholar
• [accessed Feb 10 2020]. https://www.pfizer.com/news/press-release/press-release-detail/pfizer_s_prevenar_13_receives_approval_for_use_in_infants_and_children_in_china
   Google Scholar
• Balsells E, Guillot L, Nair H, Kyaw MH. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis. PLoS One. 2017;12(5):e0177113. doi:10.1371/journal.pone.0177113.
   PubMed Web of Science ®Google Scholar
• Sørensen UB. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol. 1993;31:2097–100. doi:10.1128/JCM.31.8.2097-2100.1993.
   PubMed Web of Science ®Google Scholar
• Clinical & Laboratory Standards Institute Wayne, PA 19087, USA
   Google Scholar
• Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857–72. doi:10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E.
   PubMed Web of Science ®Google Scholar
• Chen Y, Deng W, Wang SM, Mo QM, Jia H, Wang Q, Li SG, Li X, Yao BD, Liu CJ, et al. Burden of pneumonia and meningitis caused by streptococcus pneumoniae in China among children under 5 years of age: a systemic literature review. PLoS One. 2011;6(11):1–9. doi:10.1371/journal.pone.0027333.
   Web of Science ®Google Scholar
• Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, Wang H, Lu M, So TM, Hsueh PR, Yasin RM, et al., ANSORP Study Group. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother. 2012;56(3):1418–26. doi:10.1128/AAC.05658-11.
   PubMed Web of Science ®Google Scholar
• Yao KH, YH Y. Streptococcus pneumoniae diseases in Chinese children: past, present and future. Vaccine. 2008;26(35):4425–33. doi:10.1016/j.vaccine.2008.06.052.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang H, Chen M, Sun Z, Zhao R, Zhang L, Wang H, Zhang H, Wang L, Chu Y, et al. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years. Diagn Microbiol Infect Dis. 2008;61(3):256–63. doi:10.1016/j.diagmicrobio.2008.02.004.
   PubMed Web of Science ®Google Scholar
• Xue L, Yao K, Xie G, Zheng Y, Wang C, Shang Y, Wang H, Wan L, Liu L, Li C, et al. Serotype distribution and antimicrobial resistance of streptococcus pneumoniae isolates that cause invasive disease among Chinese children. Clin Infect Dis. 2010;50(5):741–44. doi:10.1086/650534.
   PubMed Web of Science ®Google Scholar
• Molander V, Elisson C, Balaji V, Backhaus E, John J, Vargheese R, Jayaraman R, Andersson R. Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes. BMC Infect Dis. 2013;13(1):532. doi:10.1186/1471-2334-13-532.
   PubMedGoogle Scholar
• Phongsamart W, Srifeungfung S, Chatsuwan T, Nunthapisud P, Treerauthaweeraphong V, Rungnobhakhun P, Sricharoenchai S, Chokephaibulkit K. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in central Thailand, 2009-2012. Hum Vaccin Immunother. 2014;10:1866–73. doi:10.4161/hv.28675.
   PubMed Web of Science ®Google Scholar
• Shoji H, Maeda M, Takuma T, Niki Y. Serotype distribution of Streptococcus pneumoniae isolated from adult respiratory tract infections in nationwide Japanese surveillances from 2006 to 2014. J Infect Chemother. 2017;23(8):538–44. doi:10.1016/j.jiac.2017.05.003.
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhang F, Chu Y, Liu Y, Cao B, Chen M, Yu Y, Liao K, Zhang L, Sun Z, et al. Phenotypic and genotypic characteristic of invasive pneumococcal isolates from both children and adult patients from a multicenter surveillance in China 2005-2011. PLoS One. 2013;8(12):e82361. doi:10.1371/journal.pone.0082361.
   PubMed Web of Science ®Google Scholar
• Thoon KC, Chong CY, Tee NW. Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010. Int J Infect Dis. 2012;16(3):e209–15. doi:10.1016/j.ijid.2011.11.014.
   PubMed Web of Science ®Google Scholar
• Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, Lee HJ. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis. 2008;14(2):275–81. doi:10.3201/eid1402.070807.
   PubMed Web of Science ®Google Scholar
• Horácio AN, Silva-Costa C, Lopes JP, Ramirez M, Melo-Cristino J. Portuguese group for the study of streptococcal infections. serotype 3 remains the leading cause of invasive pneumococcal disease in adults in Portugal (2012-2014) despite continued reductions in other 13-valent conjugate vaccine serotypes. Front Microbiol. 2016;7:1616. doi:10.3389/fmicb.2016.01616.
   PubMed Web of Science ®Google Scholar
• Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, Adair RK, Clemens JD. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325(21):1453–60. doi:10.1056/NEJM199111213252101.
   PubMed Web of Science ®Google Scholar
• Imöhl M, Reinert RR, Ocklenburg C, van der Linden M. Association of serotypes of streptococcus pneumoniae with age in invasive pneumococcal disease. J Clin Microbiol. 2010;48(4):1291–96. doi:10.1128/JCM.01937-09.
   PubMed Web of Science ®Google Scholar
• Andrews NJ, Waight PA, Burbidge P, Pearce E, Roalfe L, Zancolli M, Slack M, Ladhani SN, Miller E, Goldblatt D. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis. 2014;14(9):839–46. doi:10.1016/S1473-3099(14)70822-9.
   PubMed Web of Science ®Google Scholar
• Galanis I, Lindstrand A, Darenberg J, Browall S, Nannapaneni P, Sjöström K, Morfeldt E, Morfeldt E, Naucler P, Blennow M, et al. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Eur Respir J. 2016;47:1208–18. doi:10.1183/13993003.01451-2015.
   PubMed Web of Science ®Google Scholar
• Silva-Costa C, Brito MJ, Pinho MD, Friães A, Aguiar SI, Ramirez M, Melo-Cristino J. Pediatric complicated pneumonia caused by streptococcus pneumoniae serotype 3 in 13-valent pneumococcal conjugate vaccinees, Portugal, 2010–2015. Emerg Infect Dis. 2018;24(7):1307–14. doi:10.3201/eid2407.180029.
   PubMed Web of Science ®Google Scholar
• Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Holtzman C, Harrison LH, Zansky SM, Rosen JB, Reingold A, Scherzinger K, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: A matched case-control study. Lancet Respir Med. 2016;4(5):399–406. doi:10.1016/S2213-2600(16)00052-7.
   PubMed Web of Science ®Google Scholar
• Van der Linden M, Falkenhorst G, Perniciaro S, Fitzner C, Imöhl M. Effectiveness of pneumococcal conjugate vaccines (PCV7 and PCV13) against invasive pneumococcal disease among children under two years of age in Germany. PLoS One. 2016;11(8):e0161257. doi:10.1371/journal.pone.0161257.
   PubMed Web of Science ®Google Scholar
• Ho PL, Law PY, Chiu SS. Increase in incidence of invasive pneumococcal disease caused by serotype 3 in children eight years after the introduction of the pneumococcal conjugate vaccine in Hong Kong. Hum Vaccin Immunother. 2019;15(2):455–58. doi:10.1080/21645515.2018.1526555.
   PubMed Web of Science ®Google Scholar
• Jansen AG, Rodenburg GD, de Greeff SC, Hak E, Veenhoven RH, Spanjaard L, Schouls LM, Sanders EA, van der Ende A. Invasive pneumococcal disease in the Netherlands: syndromes, outcome and potential vaccine benefits. Vaccine. 2009;27(17):2394–401. doi:10.1016/j.vaccine.2009.01.127.
   PubMed Web of Science ®Google Scholar
• Jansen AG, Rodenburg GD, van der Ende A, van Alphen L, Veenhoven RH, Spanjaard L, Sanders EA, Hak E. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis. 2009;49(2):e23–e29. doi:10.1086/600045.
   PubMed Web of Science ®Google Scholar
• Berg S, Trollfors B, Persson E, Backhaus E, Larsson P, Ek E, Claesson BE, Jonsson L, Radberg G, Johansson S, et al. Serotypes of Streptococcus pneumoniae isolated from blood and cerebrospinal fluid related to vaccine serotypes and to clinical characteristics. Scand J Infect Dis. 2006;38(6–7):427–3. doi:10.1080/00365540500532852.
   PubMed Web of Science ®Google Scholar